Nobuhiko Yoshida

Title: The Innovations of Nobuhiko Yoshida

Introduction

Nobuhiko Yoshida is a prominent inventor based in Tochigi-ken, Japan. He is known for his significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. His work has implications for medical treatments and diagnostics, showcasing the importance of innovation in healthcare.

Latest Patents

Yoshida holds a patent for a monoclonal antibody specific to the human α2-plasmin inhibitor. This invention provides a monoclonal antibody or its fragment that specifically blocks the site of the human α2-plasmin inhibitor, which inhibits the fibrinolytic activity of plasmin. The antibody suppresses this inhibitory function, making it useful for immunological determination, separation, or recovery of the human α2-plasmin inhibitor from various liquids. Additionally, it has potential applications in the treatment of thrombotic diseases.

Career Highlights

Nobuhiko Yoshida is associated with Teijin Limited, a company known for its advancements in various technological fields. His work at Teijin has allowed him to focus on innovative solutions that address critical health issues. With a patent portfolio that includes 1 patent, he continues to contribute to the scientific community.

Collaborations

Yoshida has collaborated with notable colleagues, including Yoshihiko Sumi and Yukiya Koike. These partnerships have fostered a collaborative environment that enhances the research and development of new technologies.

Conclusion

Nobuhiko Yoshida's contributions to the field of biotechnology through his innovative patent on monoclonal antibodies highlight the vital role of inventors in advancing medical science. His work not only addresses current health challenges but also paves the way for future innovations in treatment and diagnostics.